Management of inhibitorsWritten by Mike Makris
Professor Michael Makris is Director of the Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK . He trained in Medicine and Haematology at the Universities of Oxford, London and Sheffield in the UK. He is Professor of Haemostasis and Thrombosis at the University of Sheffield and since 1994 he has been an honorary consultant haematologist at The Sheffield Teaching Hospitals NHS Trust in Sheffield, UK.
Dr Makrisâ€™s research interests include the monitoring of adverse events in haemophilia, hepatitis C in haemophilia, thrombin generation assays in bleeding and thrombotic disorders and the genetics of inherited platelet disorders. Dr Makris is one of two editors of the journal Haemophilia. He is on the Editorial Board of the journals American Journal of Hematology, British Journal of Haematology, Acta Haematologica, Blood Transfusion and Journal of Thrombosis and Haemostasis.Website: www.linkedin.com/pub/michael-makris/19/1a1/787